help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 29, 2004
Endocrinology, doi:10.1210/en.2004-0734
A more recent version of this article appeared on April 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/4/1843    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, M.
Right arrow Articles by Pilbeam, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, M.
Right arrow Articles by Pilbeam, C.

Submitted on June 8, 2004
Accepted on December 22, 2004

DO CYCLOOXYGENASE-2 KNOCKOUT MICE HAVE PRIMARY HYPERPARATHYROIDISM?

Manshan Xu, Shilpa Choudhary, David Goltzman, Felicia Ledgard, Douglas Adams, Gloria Gronowicz, Boguslawa Koczon-Jaremko, Lawrence Raisz, and Carol Pilbeam*

Department of Medicine, University of Connecticut Health Center, Farmington, CT 06030, USA; Department of Medicine, McGill University Health Centre and McGill University, Montreal, PQ, Canada 3A 1A1; Department of Orthopedics, University of Connecticut Health Center, Farmington, CT 06030, USA

* To whom correspondence should be addressed. E-mail: pilbeam{at}nso.uchc.edu.

Absence of cyclooxygenase (COX)-2 activity in vitro reduces differentiation of both bone-forming and bone-resorbing cells. To examine the balance of COX-2 effects on bone in vivo, we studied COX-2 knockout (KO) and wild-type (WT) mice. After weaning, KO mice died 4 times faster than WT, consistent with reports of progressive renal failure in KO mice. Among KO mice killed at 4 mo of age, some had renal failure with marked secondary hyperparathyroidism, but others appeared healthy. On the assumption that renal failure was not inevitable in COX-2 KO mice and that phenotypic differences might increase with age, we studied KO mice surviving to 10 mo of age with serum creatinine similar to WT mice. In 10-mo old male KO mice, serum calcium and parathyroid hormone (PTH), but not phosphorus, levels were increased compared with WT mice. 1,25(OH)2D3 levels were markedly elevated in KO mice. Skeletal analysis showed small non-significant decreases in cortical bone density by BMD and either an increase (distal femur, µCT) or no difference (distal femur, static histomorphometry) in trabecular bone density in KO mice. There was a trend toward increased percent osteoblastic and osteoclastic surface, and on dynamic histomorphometry, the rates of trabecular bone formation (BFR/BS) and mineral apposition (MAR) were increased in KO mice relative to WT mice. Similar trends were observed for most parameters in 10- mo old female COX-2 KO mice. However, BFR/BS and MAR were increased in 10-mo old WT females compared with males and did not increase further in female KO mice. These data suggest that COX-2 KO mice with intact renal function have primary hyperparathyroidism and that effects of increased PTH and 1,25(OH)2D3 to increase bone turnover may compensate for the absence of COX-2.


Key words: prostaglandin • parathyroid hormone • renal failure • bone • 1 • 25(OH)2 D3




This article has been cited by other articles:


Home page
IBMS BoneKEyHome page
K. A. Blackwell, C. C. Pilbeam, and L. G. Raisz
Take Two Aspirin: for Osteoporosis?
IBMS BoneKEy, November 1, 2008; 5(11): 436 - 440.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society